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Introduction
Since their introduction by the Whitesides group in 2007, microuidic paper-based analytical devices (mPADs) have gained signicant attention as an analytical platform. 1 Owing to the intrinsic properties of paper, mPADs feature several advantageous characteristics relevant to simple and low-cost analytical devices: (1) they are fabricated from low-cost materials. (2) They are lightweight, making them easy to transport and to distribute. (3) They are safely disposable by incineration. Compared to plastic microplates contaminated with biological substances in laboratory tests, incineration of used mPADs enables sanitary disposal, which eliminates hazardous biological substances. (4) Assays performed on mPADs require only low sample volumes, which is important for samples with limited availability such as tears, saliva, urine from newborn infants, and blood from nger pricks.
2 (5) mPADs do generally not depend on external power sources. The need for pumps is eliminated, since capillary forces in the microporous cellulose ber network of paper drive sample transport. In sum, mPADs are easy-to-handle and user-friendly analytical tools suitable for volume-limited samples, as has already been shown in various applications (e.g. blood test, food safety, and metal analysis).
3-7
In 2008, our group had demonstrated mPADs for (bio) chemical sensing fabricated by inkjet printing technology for the rst time. 8 Among the various reported printing technologies for the microuidic patterning of paper substrates (plotting, 9 wax printing, 10,11 exographic printing, 12 wax screen printing 13 ), inkjet printing is so far the only industrially applied technology that allows performing all processing steps required for the fabrication of complete mPADs.
14,15
Human tear uid is a mixture of various components such as water, proteins, enzymes, electrolytes and lipids. The proteomics of tear uid has recently become an active area of research. 16, 17 Proteins in tears play a key role in the preservation of the ocular surface and in the adjustment of tear components. Therefore, disorders in tear protein secretion can be a cause of several diseases. It has been reported that analysis of the tear protein concentration enables their diagnosis. 18 In particular, the down-regulation of lactoferrin, a glycoprotein existing in human tear uid at relatively high concentrations, is strongly linked to disorders of the corneal epithelium, 19 and the determination of its concentration is expected to facilitate the diagnosis of systemic autoimmune diseases. So far, most methods for lactoferrin quantication reported in the literature are based on immunoassays. Examples include a conventional enzyme linked immunosorbent assay (ELISA), 20 a radial immunodiffusion assay (Lactoplate), 21 and a colorimetric solid phase immunoassay (Lactocard). 22 Although they are highly selective and sensitive, these assays have the drawbacks of being timeconsuming and requiring multiple operational steps. To overcome these disadvantages, Karns and Herr have recently developed a homogeneous electrophoretic immunoassay on a microuidic glass chip, which enables the quantication of lactoferrin in <1 mL of human tear uid within 5 s. 17 However, costs associated with the use of monoclonal anti-lactoferrin antibodies for lactoferrin capture remain an issue. In addition, the requirement for sophisticated high-tech instruments for signal detection (e.g. uorescence microscope and cooled CCD camera) makes it difficult to realize a more simple and low-cost assay. Although iTRAQ (isobaric tag for relative and absolute quantitation) technology combined with 2D-nanoLC-nanoESI-MS/MS 23 and SELDI-TOF-MS 24 have been reported as analytical methods for lactoferrin quantication without employing antibodies, they require relatively large sample volumes and rely on high cost instrumentation not commonly found in small or medium sized clinical laboratories.
This work demonstrates a simple, low-cost, and rapid lactoferrin determination in human tear uid using inkjet-printed mPADs based on uorescence detection. Inkjet printing is used for both the patterning of microchannels and the deposition of the reagents required for sensing. The assay relies on the uo-rescence emission from complexes formed between human lactoferrin in the sample solution and Tb 3+ cations printed on the sensing area of mPADs. The concentration of lactoferrin in the sample is quantied by observing the color intensity of the uorescence emitted from the complexes formed on the mPAD. This method allows for rapid analysis (15 min) of lactoferrin, based on a simple uorometric assay without using costly antibodies. The achieved detection limit is sufficiently low for the detection of deviating lactoferrin levels in human tear uid.
To the best of our knowledge, this is the rst report of a lactoferrin determination method relying neither on an immunoassay nor on high cost analytical instrumentation.
Experimental section

Reagents and instruments
All reagents were used as received. Terbium chloride hexahydrate (TbCl 3 $6H 2 O) and human lactoferrin were purchased from Sigma-Aldrich (St. Louis, MO). 1,10-Decanediol diacrylate was purchased from TCI (Tokyo, Japan). N-(2-Hydroxyethyl)-1-piperazine ethanesulfonic acid (HEPES) was purchased from Dojindo Laboratories (Kumamoto, Japan). Sodium hydroxide and poly(vinyl alcohol) were purchased from Kanto Chemical (Tokyo, Japan). The human lactoferrin ELISA kit was purchased from EMD Chemicals, Inc. (San Diego, USA). All other reagents were purchased from Wako Pure Chemical Industries Ltd (Osaka, Japan). All solutions were prepared using 18 MU Milli-Q water. Circular lter paper sheets of 185 mm diameter (Advantec No. 5C) were obtained from Toyo Roshi Co., Ltd (Tokyo, Japan). Fluorescence spectra in solution were recorded on a SPEX Fluorolog-NIR spectrophotometer (HORIBA, Kyoto, Japan). Patterning of the microuidic structures was performed on an unmodied piezoelectric EPSON PX-105 inkjet printer (Epson, Suwa, Japan), whereas the reagents for lactoferrin detection were deposited with a piezoelectric Dimatix DMP 2831 (DimatixFujilm Inc., Santa Clara, USA) material printer with 10 pL nominal droplet volume cartridges (DMC-11610). Photopolymerization of printed structures was performed under irradiation from a Hg-Xe lamp (Lightingcure LC-6, Hamamatsu Photonics, Hamamatsu, Japan) at a power of 4 mW cm
À2
(measured at 365 nm). For uorescence emission signal detection from mPADs, UV hand lamps (Funakoshi, Tokyo, Japan) were used as excitation light sources inside a Mini UV viewing cabinet (UVP, Upland, CA, USA), and the emission was captured with a DMC-FZ50 digital camera (Panasonic, Osaka, Japan) through a 520 nm longpass lter (Sigma Koki Co., Ltd, Tokyo, Japan).
Fluorescence emission measurements in solution
Fluorescence emission spectra were collected from HEPES buffered solutions (pH 7.4, 50 mM) containing 0 to 1 mg mL À1 lactoferrin in the presence of 100 mM TbCl 3 and 3.75 mM NaHCO 3 . The excitation wavelength was set to 290 nm and the emission spectra were recorded between 480 nm and 640 nm through a 440 nm longpass lter (Sigma Koki Co., Ltd, Tokyo, Japan).
Device fabrication
The microuidic patterns on mPADs were fabricated with the inkjet printer and a UV-curable ink by a method similar to the one previously reported by our group. 15 Briey, lter paper taped onto a sheet of A4 copy paper with a circular cut-out area in the center was fed into the EPSON inkjet printer. The attachment of the lter paper to a sheet of copy paper is necessary, because the paper feeder of the inkjet printer used in this work is unable to handle round shapes. With the circular cut-out in the copy paper, both surfaces of the attached lter paper are accessible for printing. The ink cartridges were loaded with the UV-curable ink based on octadecyl acrylate and 1,10-decanediol diacrylate. On the topside of the paper, microuidic patterns designed with PowerPoint (Microso) were printed. Aer the paper was ejected from the printer, it was placed on a cooling plate at 10 C, while being exposed to the UV light source for 15 min. On the backside of the paper, the UV-curable ink was deposited covering the entire area patterned on the topside, followed by cooling and UV light exposure for 10 min. With this method, 72 microuidic patterns were printed onto a 9 Â 9 cm 2 area of the lter paper in a single batch. The design of a single pattern consists of two square areas for sampling and sensing connected by a straight channel, as shown in Fig. 1 . Before cutting into single devices, all reagents required for lactoferrin detection were deposited onto the patterned paper substrates. First, 8 printing layers of 1 mM TbCl 3 solution with 15 vol% ethylene glycol were deposited onto the sensing areas. To prevent the adsorption of lactoferrin to the paper surface, the entire paper was then soaked in 50 mL of 0.5 wt% poly(vinyl alcohol) for 5 min, followed by drying for 20 min at 37 C. The soaking solution was replaced aer every use. Next, 12 printing layers of 25 mM NaHCO 3 solution were deposited onto the sampling areas. In all cases HEPES buffered solutions (pH 7.4, 50 mM) were used. In the last step, the completely processed substrate was cut into single mPADs. A schematic illustration of the reagent deposition procedure for fabricating the nal mPADs is shown in Fig. 2 .
Device calibration and quantitative data processing
For calibration and quantication of human lactoferrin levels in real samples, 2.5 mL of calibration solution (human lactoferrin in 50 mM HEPES pH 7.4 buffer) or tear sample (see below) was pipetted onto the sampling area of a mPAD. Aer complete drying at room temperature (10-12 min aer sample application), the mPAD was placed between two UV hand lamps (l ex ¼ 254 nm) in a darkened UV viewing cabinet, and the emitted green uorescence was imaged using the digital camera through the longpass lter to eliminate the inuence of excitation light reected from the paper substrate. The captured images were stored in JPEG format at 240 dpi and the green (G) intensity (RGB scale) in the sensing area was measured using the image processing soware ImageJ (National Institutes of Health). All signals are reported as DG values (G sample À G blank ).
The setup for uorescence signal capture is shown in Fig. S1 of the ESI. †
Human tear uid analysis
Human tear samples were collected from ve volunteers with disposable polyethylene pipettes (AS ONE, Osaka, Japan) and stored in autoclaved Protein LoBind tubes (Eppendorf) at 4 C until use and no longer than 3 days. For mPAD analysis of lactoferrin concentrations, undiluted human tear uid was deposited into the sampling area. For ELISA analysis, human tear samples were 10 5 -fold diluted in autoclaved Protein LoBind tubes with the sample diluting buffer provided in the kit. This step was necessary to adjust the lactoferrin concentrations to the dynamic response range of the kit (5-50 ng mL À1 ).
Results and discussion
Assay principle
The glycoprotein lactoferrin is known for its capacity to reversibly bind two iron ions in their trivalent Fe 3+ state. In this process, a bicarbonate ion acts as a synergistic anion by neutralizing a positive charge in the binding site of the protein. 25 It has also been reported that various other metal ions can be substituted for iron, including lanthanides. 26 On the other hand, the uorescence emission of terbium ions is efficiently sensitized upon binding to certain peptides or proteins. 27, 28 More recently, it has been shown that Tb 3+ ions bound to the metal ion binding site of lactoferrin emit pHdependent uorescence (l max ¼ 548 nm). 29 The uorescence intensity shows a sharp increase between pH 6 and 7 and at-tens out at around pH 7.2. Therefore, observing the intensity of the green uorescence from lactoferrin-terbium complexes at a constant pH value was expected to be applicable to the quantication of lactoferrin. While the pH-dependence of the uo-rescence emission from lactoferrin-Tb 3+ complexes has been reported, the dependence on the lactoferrin concentration has not been investigated so far. In a proof-of-concept experiment, the uorescence emission spectra of aqueous TbCl 3 solutions (100 mM) in the presence of increasing concentrations of human lactoferrin (0-1 mg mL À1 ) were recorded at a xed pH of 7.4
(50 mM HEPES buffer) and a background of 3.75 mM NaHCO 3 . In analogy to the binding of Fe 3+ to lactoferrin, 25 it was assumed that the presence of the bicarbonate anion would also strengthen the binding of Tb 3+ to the protein. In that way, NaHCO 3 acts as an indirect uorescence signal enhancer. The spectra shown in Fig. 3 , which are observed as a green Fig. 2 Schematic illustration of the reagent deposition process during fabrication of final mPADs: TbCl 3 and NaHCO 3 solutions were printed by using an inkjet printer, while surface treatment of the paper substrate was performed by soaking in poly(vinyl alcohol) solution. All reagents were dissolved in HEPES buffered solution (pH 7.4, 50 mM).
colored emission by the naked eye. The lactoferrin concentration dependent emission at 548 nm is shown in Fig. S2 (ESI †). This newly developed uorescence-based assay allows the quantication of lactoferrin without depending on antibodies or on labor-intensive and time-consuming analytical methods. However, the assay performed in solution, for example in a microtiter plate, requires sample volumes that are not readily available in the case of tear uid. In addition, a costly uores-cence microplate reader is not a standard instrument for an ophthalmologist's clinic. The elaboration of an alternative format of the Tb 3+ -based assay was regarded as an essential step towards simpler and more convenient lactoferrin determination. Therefore, a mPAD for the quantication of lactoferrin concentrations, based on the green uorescence emission (l max ¼ 548 nm) from lactoferrin-terbium complexes formed on the paper device, was developed.
mPAD design
The simple mPAD used throughout this work consists of two identical square areas connected by a single straight channel (Fig. 1a) . One of the square areas serves as the sample deposition area (sampling area), while the second one acts as the uorescence response area (sensing area). Inkjet patterning of the paper substrate with hydrophobic barriers using a UV curable ink composition was performed by a slightly modied version of our previously reported method. 15 In order to enable the fabrication of a larger number of mPADs in a single photocuring cycle, the UV irradiated area has been enlarged by increasing the distance between the light source and the paper substrate. To compensate for the weaker irradiation power per unit area caused by the larger distance from the light source, the UV irradiation time was extended from the previously reported 1 min to 15 min. This irradiation time was experimentally conrmed to be sufficient for the formation of hydrophobic barriers. To prevent the spreading of the liquid ink, which would lead to loss of structural resolution during the prolonged photocuring process, the lter paper was placed on a cooling plate at 10 C, while being exposed to the UV light source. By this modied method, 72 mPADs were produced simultaneously in every batch. A single inkjet printed microuidic pattern visualized by a red food colorant is shown in Fig. 1b . To implement the uorescence-based assay on the mPAD, three essential components were pre-deposited on the patterned paper substrate: (1) a Tb 3+ -salt, (2) a bicarbonate salt, and (3) a pH-buffer system. The storage of all required reagents in dry form on the paper device enabled lactoferrin analysis by simply applying the sample without any pretreatment. A schematic illustration of the reagent deposition process is shown in Fig. 2 . Since all reagents for printing and surface treatment were dissolved in HEPES buffered solution (pH 7.4, 50 mM), the components remaining on the mPAD in dry form guarantee a constant pH value for the entire device, eliminating the requirement to adjust the pH of biological samples. In the rst printing step, 8 layers of TbCl 3 solution were deposited into the sensing area. To reduce adsorption of lactoferrin to the paper surface during migration from the sampling area to the sensing area, mPADs were soaked in a solution of poly(vinyl alcohol) (PVA) aer terbium deposition. Among ve tested reagents (bovine serum albumin, poly(vinyl pyrrolidone), PVA, casein, and glycerol), PVA treated surfaces showed the best mobility of lactoferrin and little reduction of sample ow speed. The optimal PVA concentration in the solution was experimentally determined to be 0.5 wt%. Further details regarding the optimization of the surface treatment reagent are given in Fig. S3 (ESI †). It was found to be essential to deposit the Tb 3+ reagent before the surface treatment step. In the case of reversing the order, only weak signals were observed (data not shown). It is assumed that Tb 3+ is immobilized to the paper by strong electrostatic interactions with negative surface charges of untreated cellulose bers. 30 By modifying the paper surface with PVA before Tb 3+ printing, the retention of the reagent is assumed to decrease. In the nal printing step, 12 layers of NaHCO 3 solution were deposited into the sampling area. The concentrations of TbCl 3 and NaHCO 3 in the printing inks are kept relatively low to guarantee a stable jetting of liquids. Therefore, multiple printing cycles are required for reagent deposition. The optimal number of printing repetitions for TbCl 3 and NaHCO 3 was empirically investigated and the above-mentioned numbers were found to be the most suitable (tested number of printing layers: 4-12 layers for terbium, 11-15 layers for NaHCO 3 , data not shown).
Due to the insolubility of terbium carbonate in water, TbCl 3 and NaHCO 3 cannot be inkjet deposited in the form of a mixed solution. Furthermore, considering the synergistic role of the bicarbonate anion during metal cation binding to lactoferrin, it was assumed to be advantageous to have the bicarbonate anion and the terbium cation deposited into different areas of the mPAD. By doing so, the positive charge in the metal binding site of lactoferrin would be neutralized by bicarbonate before the protein interacts with Tb 3+ cations. This resulted in the present design of a mPAD with separate sampling and sensing areas.
Fluorescence-based lactoferrin assay on mPADs
To conrm the uorescence response of the developed mPADs, lactoferrin samples of various concentrations have been applied onto the sampling area of the devices. Because the normal tear uid lactoferrin concentrations of humans are between 0.63 and 2.9 mg mL À1 , 31 calibration solutions were prepared in the 0.1-4 mg mL À1 range. Aer application by a micropipette, the sample solution reached the sensing area within less than 1 min by capillary force driven ow through the connecting channel. mPADs were allowed to completely dry for 10-12 min at room temperature, before images of the uorescence signal emitted from the sensing area were captured under UV illumination. The calibration curve (Fig. 4a) shows a good correlation between the lactoferrin concentration and the green color intensity (on the RGB scale) in the sensing area recorded by the digital camera. The lactoferrin concentration dependent increase of the uorescence intensity was also readily observable by the naked eye (Fig. 4b) . It should be noted that the mPADs are singleuse devices. For this reason, every data point in the calibration curve (Fig. 4a ) has been measured with a separate mPAD. The assay (from the application of the sample to the uorescence signal capture) takes no longer than 15 min, which is signi-cantly shorter than the ELISA method requiring several hours. The limit of detection (LOD), calculated to be 0.30 mg mL
À1
based on a sigmoidal curve t and three times the standard deviation (3s) of the intensity of a blank sample, is below the lower limit of lactoferrin concentrations found in tear uid of healthy humans (0.63 mg mL À1 ). Additionally, the dynamic response range fully covers the normal lactoferrin concentration range of human tear uid. A further strength of the mPAD is the possibility of performing quantitative lactoferrin analysis at very low cost. A simple material cost estimation is given in Table  S1 (ESI †).
Arrangement of pre-deposited reagents on mPADs
In a further series of experiments, the inuence of the presence of NaHCO 3 as a signal-enhancing additive and the advantage of separate sampling and sensing areas connected by a ow channel compared to a simple spot test have been evaluated. By depositing NaHCO 3 solution onto the sampling area of the mPADs, lactoferrin interacts with the Tb 3+ cations in the sensing area aer being in contact with bicarbonate. It was experimentally conrmed that the presence of HCO 3 À in a distinct area from the sensing area improved the performance of the mPADs. For comparison purposes, simple spot tests with NaHCO 3 and TbCl 3 pre-deposited by inkjet-printing of separate solutions into a 3 Â 3 mm 2 area surrounded by inkjet printed hydrophobic barriers were fabricated (Fig. S4a †) . Similarly to the mPAD arrangement, these spot tests showed increasing Tb 3+ uorescence emission depending on the lactoferrin concentrations. However, as shown in Fig. S4b (ESI †) , the observed sensitivity, expressed as the total green intensity signal change between a blank sample and a sample containing 4 mg mL À1 of lactoferrin, was lower (DG max ¼ 135) than in the case of mPADs with separate sampling and sensing areas connected by a ow channel (DG max ¼ 144) (Fig. 4a) . For a bicarbonate-free spot test arrangement with only the Tb 3+ sensing reagent (Fig. S4c †) , the sensitivity in terms of total signal change was further reduced (DG max ¼ 119). Fig. S5 (ESI †) compares a set of calibration curves for lactoferrin obtained with mPADs with separate sampling and sensing areas in the presence (red line) and absence (blue line) of NaHCO 3 printed onto the sampling area.
As in the case of the spot test, the measured DG signals are larger in the presence of the additive. Although the observed differences are not very large, the same trend was noted throughout all experiments performed with paper devices in this study. In all cases, the use of mPADs with separate sampling and sensing areas connected by a microuidic channel, where NaHCO 3 had been pre-deposited onto the sampling area, showed the highest sensitivities.
Shelf life of mPADs
The shelf life of the developed mPADs was investigated. For this purpose, devices were stored at room temperature (25 C) wrapped in aluminum foil to protect against ambient light for up to 100 days aer fabrication. Alternatively, they were kept in a dark climate control chamber at 35 C and 50% relative humidity for 10 days. Calibration curves obtained by applying lactoferrin samples to the mPADs stored under various conditions are shown in Fig. S6 (ESI †). Upon storing at room temperature, a reduction in sensitivity is observed aer a period of 30 days (Fig. S6a †) . In the case of storage at increased temperature (35 C) , the onset of decreasing sensitivity is observed aer a 10-day period (Fig. S6b †) . However, according to the calculated limits of detection (LOD) and limits of quantication (LOQ) shown in Table S2 , † the mPADs remain functional for at least 45 days when stored at room temperature, as long as proper calibration is performed at the time of use. Aer a storage period of 100 days, a signicant change in the calibration curve accompanied by a general deterioration of LOD and LOQ was observed. As for the reasons of degradation, a reduction in sample ow speed aer extended storage has been experimentally observed. This assumedly results in a lower amount of lactoferrin reaching the sensing area, leading to a sensitivity decrease. The causes for the reduction in sample ow speed are so far not known. However, the fact that mPADs can be stored at room temperature is a clear advantage over the currently commercially available ELISA kits for lactoferrin detection, which require constant refrigeration to preserve the functionality of the used antibodies.
Selectivity evaluation
Human tear uid consists of various substances including proteins and electrolytes. Primary constituents and their concentrations are shown in Table 1 . Before applying the mPADs to the analysis of human tear uid samples, possible interference of these components was investigated. Fig. 5 summarizes the results of the interference study. None of the primary tear constituents except lactoferrin resulted in a signicant uo-rescence signal (indicated as DG) when applied as single components to the mPADs (Fig. 5 , blue bars) at concentrations indicated in Table 1 . This demonstrates the high selectivity of the sensitizing interaction between Tb 3+ and lactoferrin. In addition, the major tear uid constituents did not interfere with the terbium sensitization by lactoferrin. This was conrmed by the identical uorescence signals observed in mixed solutions of Tb 3+ and other tear uid constituents (Fig. 5 , orange bars).
Thus, it has been clearly demonstrated that the mPADs respond to none of the major tear uid constituents except lactoferrin, and that the presence of other constituents does not block the binding of lactoferrin to Tb 3+ .
Quantitative measurements of lactoferrin concentrations in human tear uid
Quantitative lactoferrin analysis in human tear uid from several volunteers was performed. The concentrations of lactoferrin in tear uids were determined by using the developed mPADs. For validation purposes, the assay results were compared to those obtained by the ELISA method. Human tear samples were collected from the inferior cul-de-sac of ve volunteers. The results of human tear analysis shown in Table 2 indicate that all samples were correctly analyzed with the developed mPADs within 6% error of the ELISA method. The direct comparison of the two different methods (Fig. S7 †) shows a linear correlation coefficient R 2 of 0.9907, with a slope close to unity (0.9762) and a y-axis intercept close to zero (0.0725). A major conceptual difference between the mPAD assay and the ELISA method is the fact that the immunoassay detects the total concentration of lactoferrin, independent of its iron saturation state, while complex formation between lactoferrin and terbium on the mPAD occurs only with the iron free apo-lactoferrin. However, in the case of tear uid, it is known that lactoferrin is essentially present only in its apo-form. 36 This is conrmed by the identical results within 6% error of lactoferrin concentrations measured by mPADs and by the ELISA method.
In the case of lactoferrin analysis with mPADs, small standard deviations were observed, with the exception of sample 5, which showed a relatively large value owing to its concentration being lactoferrin was used for selectivity evaluation. Table 1 . The data reflect the average and standard deviations of three measurements. a Measured values were calculated from a calibration curve and the green intensity in the sensing area obtained by applying 2.5 mL of tear samples. The data reect the average values and standard deviations of three measurements. b Tear samples were diluted 10 5 -fold before use with the sample diluting buffer provided in the kit. The data reect the average values and standard deviations of four measurements.
c Error (%) calculated as 100 Â (mPAD À ELISA)/ELISA.
at the upper limit of the dynamic response range of the mPAD. Upon two-fold dilution of this sample with HEPES buffered solution, the analysis resulted in a value of 1.74 AE 0.11 mg mL
À1
with a signicantly lower standard deviation.
Conclusions
A rapid, user-friendly and low-cost sensing device for analysis of lactoferrin in human tear uid was successfully developed. Lactoferrin detection was achieved by measuring the uorescence emitted from lactoferrin-terbium complexes formed on the paper devices. This is to the best of our knowledge the rst report of a quantitative lactoferrin assay without the requirement of using antibodies or high cost analytical instrumentation. It has been conrmed that the uorescence emission intensity increases in proportion to the lactoferrin levels in the sample, which even allows detection by the naked eye. By applying lter paper as the sensing platform, a low-cost, light-weight, and easily and safely disposable device has been realized. Although the achieved limit of detection was much higher compared to the one reported for the ELISA kit (1 ng mL À1 ), the developed mPAD is a prospective alternative method for simple lactoferrin determination at concentrations encountered in human tear uid usable by non-trained personnel. Assay results can be obtained within 15 min by simply pipetting a freshly collected tear sample to the sampling area. In contrast to the ELISA method requiring several hours of multiple pipetting, incubation, and washing procedures, the simplicity of the mPAD makes it a widely applicable sensing tool for rapid diagnosis. Finally, the detection system proposed here is expected to be adaptable to the sensing of other metal binding proteins by changing the probe deposited on the sensing area.
